Callan Capital LLC Buys 1,103 Shares of The Procter & Gamble Company (NYSE:PG)

Callan Capital LLC lifted its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 33.6% in the 4th quarter, HoldingsChannel reports. The fund owned 4,389 shares of the company’s stock after purchasing an additional 1,103 shares during the quarter. Callan Capital LLC’s holdings in Procter & Gamble were worth $643,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Demars Financial Group LLC lifted its holdings in Procter & Gamble by 4.4% in the fourth quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock worth $219,000 after acquiring an additional 63 shares during the last quarter. Emerald Advisors LLC raised its holdings in shares of Procter & Gamble by 1.8% during the fourth quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock valued at $553,000 after buying an additional 65 shares during the last quarter. O Brien Wealth Partners LLC raised its holdings in shares of Procter & Gamble by 3.3% during the fourth quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock valued at $302,000 after buying an additional 65 shares during the last quarter. KFA Private Wealth Group LLC raised its holdings in shares of Procter & Gamble by 2.2% during the third quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock valued at $445,000 after buying an additional 67 shares during the last quarter. Finally, Chemistry Wealth Management LLC raised its holdings in shares of Procter & Gamble by 1.2% during the fourth quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock valued at $856,000 after buying an additional 67 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company lifted their price target on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft dropped their target price on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a report on Monday. Barclays boosted their target price on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a report on Tuesday. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Finally, Jefferies Financial Group boosted their target price on Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a report on Monday. Seven equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $169.76.

Check Out Our Latest Report on Procter & Gamble

Procter & Gamble Trading Down 0.8 %

NYSE PG traded down $1.31 on Friday, hitting $161.24. 5,659,643 shares of the stock were exchanged, compared to its average volume of 6,957,020. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $164.32. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The company has a market capitalization of $380.55 billion, a price-to-earnings ratio of 26.35, a P/E/G ratio of 3.30 and a beta of 0.44. The company’s 50-day moving average price is $159.64 and its two-hundred day moving average price is $153.51.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. During the same period in the previous year, the company posted $1.37 EPS. The company’s quarterly revenue was up .6% compared to the same quarter last year. Research analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.50%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. Procter & Gamble’s payout ratio is presently 65.85%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction on Monday, January 29th. The shares were sold at an average price of $156.00, for a total transaction of $7,020,000.00. Following the completion of the sale, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $151,788. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction on Monday, January 29th. The shares were sold at an average price of $156.00, for a total value of $7,020,000.00. Following the completion of the sale, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $151,788. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Susan Street Whaley sold 3,865 shares of Procter & Gamble stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the completion of the sale, the insider now directly owns 11,886 shares of the company’s stock, valued at approximately $1,908,891.60. The disclosure for this sale can be found here. Insiders sold 100,865 shares of company stock valued at $16,029,280 in the last quarter. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.